- For Career: +91-7807836763
- For Business : +91-7807096339
- E-mail : biozenta@gmail.com
Biozenta pursuing and exporting to over 30+ countries across the continents globally which include Asia, Africa, LATAM, CIS, MENA and Europe. With over 180+ international product registrations (many more are under registrations), Biozenta is emerging as one of the leading and fast growing major Indian pharmaceutical manufacturer and exporter. Biozenta is aggressively participating in all the Govt, MOH and local tenders of pharmaceutical formulations, across the globe.
Biozenta strives to be a world class pharmaceutical manufacturer for the development and providing high quality products with superior performance at affordable price. Biozenta's formulation development and regulatory teams are focused on developing the latest generics to the global markets, with a commitment for continuous flow of innovative products across the globe, in all the therapeutic categories - Oncology, Anti-cancer, Cytotoxic, Critical-care, Life-saving, General Injectables, Contrast Media Injectables, Oral Solids - Tablets and Capsules – including Ant-retrovirals (ARVs), External Preparations – Derma and Cosmetics and also vertically integrated for key Oncology Active Pharmaceutical Ingredients (API’s).
Biozenta has a dedicated and well established regulatory department responsible for arranging the documents and meeting the world-wide regulatory requirements to meet international audit compliance and providing complete CTD / eCTD / ACTD format dossiers, operating in full compliance with C-GMP norms, the manufacturing unit of has been awarded certification by multiple regulatory agencies.
Biozenta has left a major 'Mark of Excellence' on Atlas with stable formulations, timely delivery and ease of operations. Biozenta has expanded its reach to various parts of the world and carved a promising niche for the company.
As a result of timely and effective delivery, an orientation towards customer satisfaction and individual customization of products to meet specific requirements, Biozenta have gained worldwide recognition for its services and products within a very short span of time.
| Asia | Fiji, Singapore, Philippines, Vietnam, Myanmar, Cambodia, Srilanka, Indonesia, Malaysia, S. Korea, Pakistan, Nepal, Bhutan, Bangladesh, Mauritius. |
| Africa | South Africa, Zimbabwe, Namibia, Botswana, Kenya, Tanzania, Uganda, Zambia, Rwanda, Malawi, Nigeria, Ghana, Ethiopia, Serra Leone, Somalia, Eretria, FWA region. |
| Latin America | Panama, Costa Rica, Dominican Republic, Guatemala, Guyana, Peru, Chile, Bolivia , Brazil, Bahamas, Ecuador. |
| CIS | Russia, Belorussia, Ukraine, Azerbaijan, Kazakhstan, Kyrgyzstan, Uzbekistan, Georgia, Armenia, Moldova, Turkeministan, Tajikistan. |
| Mena Region | UAE, Saudi Arabia, GCC countries, Jordan, Egypt, Libya, Algeria, Morocco, Tunisia, Turkey. |
| Europe | Austria , Germany, Spain, Sweden, Switzerland , Latvia. |
Key Principles of Global Business:
Biozenta believes in working together towards success, with mutual trust, understanding and meeting its partner's requirements.
Biozenta makes its products available to local pharmaceutical distributors in most countries. Biozenta support its partners with manufacturing and supply of pharmaceutical products according to their requirements and specifications. Biozenta provide the marketing support to its partners with its commitment from its business development and Regulatory team always available for its customer's service.
Biozenta build "molecules into brands" and work with its customers, strategically and programmatically, to accelerate, expand and extend the product life cycles of ethical drugs. Biozenta have developed considerable brand marketing experience in the emerging markets through its product portfolio of the branded generics. Biozenta focus on new generation of drugs thereby ascending the value chain in the marketing and ultimately increase revenues from the sales of its products.
Biozenta understand that distribution of pharmaceutical products must be undertaken with a great deal of care and attention. Raw materials awaiting processing and finished products awaiting dispatch are stored in modern, fully climate-controlled high-bay storage areas. Biozenta is able to meet the delivery needs of its customers thanks to its modern data and order processing systems, its inspections of all products entering and leaving the factory, and the latest transport logistics (road, sea or air).
(Biozenta Participating in all Events)
| Events | Dates |
|---|---|
| Ghana | 16-18 May 2023 |
| Belarus (Wegworus) | 23-26 May 2023 |
| Uzbekistan (Wegwors) | 7-9 June 2023 |
| CPHI & PMEC (Shanghai) | 19-21 June 2023 |
| IPHEX Hyderabad | 5-7 July 2023 |
| Nigeria (Wegworus) | 18-20 July 2023 |
| CPHI Bangkok, Thailand | 16-18 August 2023 |
| Iran | 27-29 September 2023 |
| CPHI Worldwide (Barcelona) | 24-26 October 2023 |
| CPHI & PMEC India | 28-30 November 2023 |
Phone
